Schwamborn, Kristina http://orcid.org/0000-0003-3717-0823
Ammann, Johannes U
Knüchel, Ruth
Hartmann, Arndt
Baretton, Gustavo
Lasitschka, Felix
Schirmacher, Peter
Braunschweig, Till
Tauber, Robert
Erlmeier, Franziska
Hieke-Schulz, Stefanie
Weichert, Wilko
Funding for this research was provided by:
Roche Pharma AG, Grenzach-Wyhlen, Germany (NA)
Article History
Received: 18 March 2019
Revised: 5 June 2019
Accepted: 18 June 2019
First Online: 2 July 2019
Compliance with ethical standards
:
: KS: grants or funding, Roche and MSD. JUA: employment and stockholding, Roche. RK: advisory board, Roche and BMS. AH: advisory board, Roche, MSD, and AstraZeneca; sponsored research, Novartis, BioNTech, Illumina, NanoString, and Qiagen. GB: grants or funding, Roche and BMS; advisory board, Roche, BMS, AstraZeneca, and MSD. FL: grants or funding, Roche; advisory board, Roche and BMS. PS: grants or funding, Roche, AstraZeneca, Novartis, Chugai, and Sanofi Aventis; honoraria, Roche, BMS, MSD, AstraZeneca, and Novartis. TB: grants or funding, Roche; advisory board, BMS; honoraria, Roche, MSD, and BMS. RT: grants or funding, Roche; consultancy, Roche and Sanofi; honoraria, Roche, BMS, Ipsen, Bayer, Sanofi, and Thieme; advisory board; Roche, Sanofi, and BMS. FE: none. SH-S: employment, Roche. WW: grants or funding, Roche, BMS, MSD, and Bruker Daltonik; consultancy, Roche, Pfizer, AstraZeneca, MSD, BMS, Merck, and Novartis; speakers' bureau, Roche, Pfizer, AstraZeneca, MSD, BMS, Novartis, Lilly, Takeda, Boehringer, and Amgen.All authors received support for third-party writing assistance for this manuscript, provided by Roche Pharma AG, Grenzach-Wyhlen, Germany.Employees of the sponsor who are authors of the manuscript (JUA., SH-S) were involved in study design, collection, analysis, and interpretation of data, writing of the report, and in the decision to submit the report for publication.
: This was a non-interventional study on archived tissue samples.